Goldman Sachs
PPH icon

Goldman Sachs’s VanEck Pharmaceutical ETF PPH Stock Holding History

Goldman Sachs’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102M Buy
986,112
+168,830
+21% +$18M 0.01% 1011
2025
Q4 		$84.3M Sell
817,282
-1,079,719
-57% -$105M 0.01% 1116
2025
Q3 		$171M Sell
1,897,001
-865,769
-31% -$75.8M 0.02% 677
2025
Q2 		$243M Buy
2,762,770
+1,602,598
+138% +$139M 0.03% 501
2025
Q1 		$106M Sell
1,160,172
-1,131,549
-49% -$102M 0.02% 754
2024
Q4 		$198M Buy
2,291,721
+194,720
+9% +$17.6M 0.03% 507
2024
Q3 		$199M Buy
2,097,001
+650,000
+45% +$61.7M 0.03% 519
2024
Q2 		$132M Buy
1,447,001
+100,000
+7% +$8.93M 0.02% 661
2024
Q1 		$122M Sell
1,347,001
-49,999
-4% -$4.38M 0.02% 684
2023
Q4 		$114M Sell
1,397,000
-250,971
-15% -$19.7M 0.02% 720
2023
Q3 		$132M Buy
1,647,971
+532,285
+48% +$42.9M 0.03% 590
2023
Q2 		$87.9M Sell
1,115,686
-484,213
-30% -$37.9M 0.02% 778
2023
Q1 		$124M Sell
1,599,899
-252,488
-14% -$19.5M 0.03% 597
2022
Q4 		$144M Sell
1,852,387
-249,870
-12% -$18.4M 0.04% 545
2022
Q3 		$141M Buy
2,102,257
+1,742,570
+484% +$128M 0.04% 523
2022
Q2 		$27.6M Buy
359,687
+212,560
+144% +$16.6M 0.01% 1629
2022
Q1 		$11.7M Sell
147,127
-209
-0.1% -$16K ﹤0.01% 2530
2021
Q4 		$11.3M Buy
147,336
+209
+0.1% +$15.5K ﹤0.01% 2643
2021
Q3 		$10.7M Hold
147,127
– – ﹤0.01% 2654
2021
Q2 		$10.7M Sell
147,127
-1,300,000
-90% -$92.7M ﹤0.01% 2627
2021
Q1 		$99.9M Buy
1,447,127
+1,227,000
+557% +$84.5M 0.03% 652
2020
Q4 		$14.6M Hold
220,127
– – ﹤0.01% 2133
2020
Q3 		$13.7M Sell
220,127
-44,373
-17% -$2.81M ﹤0.01% 2054
2020
Q2 		$16.5M Hold
264,500
– – 0.01% 1838
2020
Q1 		$14.4M Sell
264,500
-79,500
-23% -$4.89M 0.01% 1774
2019
Q4 		$22.1M Sell
344,000
-20,000
-5% -$1.21M 0.01% 1774
2019
Q3 		$20.7M Buy
364,000
+200,000
+122% +$11.5M 0.01% 1741
2019
Q2 		$9.62M Sell
164,000
-286,000
-64% -$16.6M ﹤0.01% 2383
2019
Q1 		$27.3M Sell
450,000
-250,012
-36% -$14.8M 0.01% 1599
2018
Q4 		$38.4M Sell
700,012
-100,116
-13% -$6.06M 0.01% 1288
2018
Q3 		$51.5M Sell
800,128
-8,961
-1% -$558K 0.01% 1198
2018
Q2 		$47.7M Buy
809,089
+158,363
+24% +$9.18M 0.01% 1239
2018
Q1 		$37M Buy
650,726
+400,591
+160% +$23.9M 0.01% 1389
2017
Q4 		$14.8M Sell
250,135
-100,800
-29% -$5.78M ﹤0.01% 2165
2017
Q3 		$20.3M Buy
350,935
+873
+0.2% +$49.6K 0.01% 1978
2017
Q2 		$20.7M Sell
350,062
-400,000
-53% -$22.6M 0.01% 1906
2017
Q1 		$41.4M Buy
750,062
+200,000
+36% +$10.8M 0.01% 1353
2016
Q4 		$28.9M Sell
550,062
-1,250,046
-69% -$66.8M 0.01% 1686
2016
Q3 		$103M Buy
1,800,108
+285,246
+19% +$17.1M 0.03% 693
2016
Q2 		$88.8M Sell
1,514,862
-4,942
-0.3% -$288K 0.03% 738
2016
Q1 		$87.4M Buy
1,519,804
+14,796
+1% +$875K 0.03% 737
2015
Q4 		$98.3M Buy
1,505,008
+359,211
+31% +$23.2M 0.03% 682
2015
Q3 		$72.2M Buy
1,145,797
+852
+0.1% +$59.9K 0.02% 816
2015
Q2 		$81M Buy
1,144,945
+692,032
+153% +$49.8M 0.03% 797
2015
Q1 		$31.8M Buy
452,913
+87,754
+24% +$5.95M 0.01% 1431
2014
Q4 		$23.5M Sell
365,159
-292,029
-44% -$18.6M 0.01% 1712
2014
Q3 		$41.8M Buy
657,188
+402,648
+158% +$24.9M 0.01% 1210
2014
Q2 		$15.8M Buy
254,540
+200,900
+375% +$11.9M ﹤0.01% 1991
2014
Q1 		$3.13M Sell
53,640
-11,610
-18% -$657K ﹤0.01% 3549
2013
Q4 		$3.46M Buy
65,250
+100
+0.2% +$5.06K ﹤0.01% 3491
2013
Q3 		$3.12M Sell
65,150
-1,301
-2% -$61.7K ﹤0.01% 3452
2013
Q2 		$3.02M Buy
+66,451
New +$3.07M ﹤0.01% 3274

Other funds holding PPH

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs's PPH Position: Q1 2026 in Review

Goldman Sachs increased its VanEck Pharmaceutical ETF (PPH) stake by 21% in Q1 2026, buying an estimated $18M and bringing the position to 986,112 shares worth $102M. The position accounts for 0.01% of the portfolio, ranked #1011.

Goldman Sachs first reported a position in PPH in Q2 2013 and has held it in 52 quarters since. The position peaked at $243M in Q2 2025. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Goldman Sachs held 986,112 shares of VanEck Pharmaceutical ETF worth $102M as of Q1 2026.
  • Goldman Sachs bought 168,830 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $18M.
  • VanEck Pharmaceutical ETF made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1011 holding.
  • Goldman Sachs first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's VanEck Pharmaceutical ETF position peaked at $243M in Q2 2025.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.